CN Patent

CN109154603A — 用于治疗真菌感染的给药方案

Assigned to Seachaid Pharmaceuticals LLC · Expires 2019-01-04 · 7y expired

What this patent protects

本公开的特征在于药物组合物、方法和试剂盒，其特征在于给药方案和CD101或其药学上可接受的盐或中性形式(例如，CD101乙酸盐)。

USPTO Abstract

本公开的特征在于药物组合物、方法和试剂盒，其特征在于给药方案和CD101或其药学上可接受的盐或中性形式(例如，CD101乙酸盐)。

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: CN109154603A
Jurisdiction: CN
Classification: —
Expires: 2019-01-04
Drug substance claim: No
Drug product claim: No
Assignee: Seachaid Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.